TopProp Fantasy & Encapsulate

At the Beacon meeting held on February 8, 2022, members entertained new company funding proposals from the following:

  • TopProp Fantasy, offering a daily fantasy sports platform that simplifies DFS down to its core: single-player fantasy; and
  • Encapsulate, which is develops an automated tumor-on-a-chip system to grow patient-derived microtumors, to screen them against a variety of chemotherapeutic drugs.

Members reported on the new company funding round of NF2 Therapeutics, together with that of Cognoptix, which raised $740K of a targeted $500-$700K convertible debt round to revamp and supplement the results of its most recent clinical trials.

Members delivered due diligence reports on the following companies:

  • Dyad Medical, which is developing AI-enabled clinical applications to assist cardiologists in the interpretation of medical images;
  • Jaia Robotics, developing “JaiaBots,” low-cost, high-speed, micro-sized autonomous aquatic robots that work in pods of up to 20 to collect aquatic data from coastal waters down to 100m, estuaries, rivers, lakes and marshlands; and
  • Imago Rehab, providing a virtual clinic using telerehab supplemented by a robotic glove to facilitate daily, high-repetition rehabilitation to hand-impaired stroke patients.

Beacon Angels members delivered company updates.

About Angel Treaty

Dedicated to fostering due diligence sharing between angel groups.
This entry was posted in Beacon Angels Events, Beacon Angels Exits, Beacon Events, Boston angel investing and tagged , , , . Bookmark the permalink.